Adalimumab biosimilar market shares have steadily increased, but challenges remain due to pricing strategies and limited government support, according to the Samsung Bioepis report.

Insulin Biosimilar MarketThe global insulin biosimilar market is on track for significant expansion, with an estimated valuation of approximately USD 3,008.0 million in 2024. Exhibiting a year-on-year ...

A recent study conducted by researchers from The GRADE Study Research Group looked at how well different medications work ...

A settlement by Wyoming Attorney General Bridget Hill guarantees that residents who are not enrolled in government health ...

Although HbA1c testing remains the gold standard for glucose monitoring in type 1 and type 2 diabetes, limitations include ...

A major study has provided new insights into how well different medications work to control type 2 diabetes when used ...

While all five FTC commissioners voted to issue the Report, both Republican commissioners also issued separate statements expressing concerns about specific aspects of the Report. In a separately ...

RIVERTON (WNE) — When Kathleen Pehringer’s daughter came home from school, her mother wasn’t there. Kathleen’s purse and ...

CHEYENNE — Following the presence of the Center for Technology and Civic Life at the Wyoming Association of County Officers’ meeting in Rock Springs on Sept. 25, Wyoming Secretary of State Chuck Gray ...

In the QWINT-1 phase 3 clinical trial, 796 participants were randomly selected to receive either the weekly efsitora injection or a daily injection of insulin glargine for 52 weeks. At the end of ...